Showing 1951-1960 of 2038 results for "".
- Oculis Announces Dosing of First Patient in Randomized Phase 2b (SKYGGN) Clinical Trial of OCS-01 for the Treatment of Inflammation and Pain Following Cataract Surgeryhttps://modernod.com/news/oculis-announces-dosing-of-first-patient-in-randomized-phase-2b-skyggn-clinical-trial-of-ocs-01-for-the-treatment-of-inflammation-and-pain-following-cataract-surgery/2476947/Oculis announced the dosing of the first patient in a phase 2b clinical trial evaluating the efficacy and safety of OCS-01 for the treatment of inflammation and pain following cataract surgery. OCS-01 is a unique topical formulation of dexamethasone based on the company’s proprietary
- Allergan Expands Refresh Portfolio With New Refresh Relieva Lubricant Eye Drop Product Linehttps://modernod.com/news/allergan-expands-refresh-portfolio-with-new-refresh-relieva-lubricant-eye-drop-product-line/2476943/Allergan announced the launch of three new over-the-counter Refresh Relieva products: Refresh Relieva, Refresh Relieva PF (preservative-free) multidose, and Refresh Relieva for Contacts. This new line of artificial tear formulations available in preserved, preservative-free multidose, and a form
- Tangible Science and VSP Optics Co-develop New Daily Disposable Silicone Hydrogel Contact Lenshttps://modernod.com/news/tangible-science-and-vsp-optics-co-develop-new-daily-disposable-silicone-hydrogel-contact-lens/2476916/Tangible Science announced the launch of Unity BioSync contact lenses, which the company is describing as the first daily disposable silicone hydrogel contact lens featuring a modified formula of the patented Tangible Hydra-PEG polymer technology that is bonded to the surface of the lens. Co-deve
- Pharmaceutical Companies Face Steeper Price Cuts in China as Country Expands Drug Bulk-Buying Scheme Nationwidehttps://modernod.com/news/pharmaceutical-companies-face-steeper-price-cuts-in-china-as-country-expands-drug-bulk-buying-scheme-nationwide/2476915/China has expanded across the country a drug procurement program aimed at reducing the cost of generic medicines, a move that may force global pharmaceutical firms to slash their prices by half in order to maintain sales to the country’s public hospitals, Bloomberg
- Vertical Pharmaceuticals Announces Submission of New Drug Application for RVL-1201https://modernod.com/news/vertical-pharmaceuticals-announces-submission-of-new-drug-application-for-rvl-1201/2476894/Vertical Pharmaceuticals, a subsidiary of Osmotica Pharmaceuticals, announced the submission of a new drug application (NDA) to the FDA for approval of RVL-1201 (RVL) for the treatment of acquired blepharoptosis (droopy eyelid). RVL is a novel, once-daily ophthalmic formulation of oxymeta
- Oculis Announces Appointment of Leading Ophthalmology Specialists to Scientific Advisory Boardhttps://modernod.com/news/oculis-announces-appointment-of-leading-ophthalmology-specialists-to-scientific-advisory-board/2476888/Oculis SA announced the appointments of Eric Donnenfeld, MD, and Pr. Ramin Tadayoni, MD, PhD, to its Scientific Advisory Board (SAB). “I am pleased to welcome Eric and Ramin to our SAB and look forward to their contributions as we focus on our objective of developing topical medicines that
- Atia Vision Announces Upcoming Presentations Highlighting Modular Presbyopia-Correcting IOL Technologyhttps://modernod.com/news/atia-vision-announces-upcoming-presentations-highlighting-modular-presbyopia-correcting-iol-technology/2476867/Atia Vision announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris, France. The first presentation will be delivered by the company during the Ophthalmology Futures European Forum, a clinician-driven global m
- Now Optics Names Two Women to its Executive Leadership Teamhttps://modernod.com/news/now-optics-names-two-women-to-its-executive-leadership-team/2476834/Now Optics recently named two women to its leadership team. Former CVS Health’s Morgan Diaz joined Now Optics as senior vice president of operations and business development, and Lukana Justin previously from Office Depot Inc. is the new, senior vice president of marketing. They join Tara Pellegr
- Examining the Role of Vitamin B3 Supplementation in Reducing and Preventing Retinal Cell Damage Caused by Glaucomahttps://modernod.com/news/examining-the-role-of-vitamin-b3-supplementation-in-reducing-and-preventing-retinal-cell-damage-caused-by-glaucoma/2476813/UK-based Fight for Sight is funding researchers at Cardiff University to examine the extent to which dietary supplementation of Nicotinamide—a form of vitamin B3—can be used to reduce, and even prevent, retinal damage caused by glaucoma. This important research could help pave the way for new typ
- Trial of Tele-Ophthalmology System at Regional Health Board in Scotland Shows Promising Resultshttps://modernod.com/news/trial-of-tele-ophthalmology-system-at-regional-health-board-in-scotland-shows-promising-results/2476808/Researchers at the University of Strathclyde and NHS Forth Valley in Scotland have developed a tele-ophthalmology system that, according to recent data, has reduced the need for follow-up appointments and waiting times for treatments in over 50% of cases, according to a